Weibo Pan
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Rheumatology top 10%
- Bone Tumor Diagnosis and Treatments
Papers in
-
- Bone Tumor Diagnosis and Treatments 5
-
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- Zhaoming Ye (10 shared papers)Nong Lin (10 shared papers)Xiaobo Yan (8 shared papers)Haibao Wang (1 shared paper)Xin Huang (5 shared papers)Zhan Wang (4 shared papers)Binghao Li (5 shared papers)Hengyuan Li (4 shared papers)
- Journals
- Journal of Cancer (2 papers)Oncotarget (1 paper)Cancer Research (1 paper)European Spine Journal (1 paper)Cellular Physiology and Biochemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weibo Pan
16 papers receiving 462 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 99
- Rheumatology 83
- Pulmonary and Respiratory Medicine 144
- Oncology 67
- Radiology, Nuclear Medicine and Imaging 54
Countries citing papers authored by Weibo Pan
This map shows the geographic impact of Weibo Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Pan more than expected).
Fields of papers citing papers by Weibo Pan
This network shows the impact of papers produced by Weibo Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Pan. The network helps show where Weibo Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Weibo Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 101 | |
| 2 | 2018 | 76 | |
| 3 | 2014 | 73 | |
| 4 | 2019 | 45 | |
| 5 | 2019 | 33 | |
| 6 | 2018 | 22 | |
| 7 | 2021 | 22 | |
| 8 | 2018 | 19 | |
| 9 | 2021 | 17 | |
| 10 | 2013 | 16 | |
| 11 | 2017 | 13 | |
| 12 | 2016 | 11 | |
| 13 | 2016 | 8 | |
| 14 | 2012 | 7 | |
| 15 | 2014 | 3 | |
| 16 | 2023 | 1 | |
| 17 | 2024 | 0 |
About Weibo Pan
Weibo Pan is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Oncology, Control and Systems Engineering and Industrial and Manufacturing Engineering, having authored 17 papers that have together received 467 indexed citations. Recurring topics across this work include Bone Tumor Diagnosis and Treatments (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Industrial Technology and Control Systems (2 papers), Pelvic and Acetabular Injuries (2 papers), Cancer Genomics and Diagnostics (1 paper), interferon and immune responses (1 paper), Engineering Applied Research (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (99 citations), Rheumatology (83 citations), Pulmonary and Respiratory Medicine (144 citations), Oncology (67 citations) and Radiology, Nuclear Medicine and Imaging (54 citations). Weibo Pan has collaborated with scholars based in China and United States. Frequent co-authors include Zhaoming Ye, Nong Lin, Xiaobo Yan, Haibao Wang, Xin Huang, Zhan Wang, Binghao Li, Hengyuan Li, Meng Liu and Xin Huang. Their work appears in journals such as Journal of Cancer, Oncotarget, Cancer Research, European Spine Journal and Cellular Physiology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.